SCHEMBL8923960

SCHEMBL8923960

CCOC(=O)C(F)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
LMNA P02545 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ALOX15 P16050 1/20 0.40
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40
SOAT1 P35610 1/20 0.40
EGLN1 Q9GZT9 1/20 0.39
PIN1 Q13526 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
KMT2A Q03164 1/20 0.37
TRPA1 O75762 1/20 0.37
MAPT P10636 1/20 0.35
MMP8 P22894 1/20 0.35
CYP2D6 P10635 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18666926 1.00 ALDH1A1 (0.43) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL223479 0.87 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL30870369 0.80 ALDH1A1 (0.43) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL250103 0.80 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL3782518 0.78 SOAT1 (0.44) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL457732 0.78 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL8306235 0.78 ALDH1A1 (0.50) ALDH1A1LMNAHCAR2MAPTCYP2D6
SCHEMBL28813392 0.77 OR51E2 (0.32)
Potassium Ion SCHEMBL30409183 0.76 ALDH1A1 (0.40) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL7406646 0.76 ALDH1A1 (0.40) ALDH1A1LMNAHSD17B10ALOX15MGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120424432-B Scratch-resistant PE composite board and preparation method thereof 江西旭联新材料有限责任公司 2025-09-05 CN disclosed
CN-120424432-A Scratch-resistant PE composite board and preparation method thereof 江西旭联新材料有限责任公司 2025-08-05 CN disclosed
US-20240174599-A1 MALONAMIDES AND THEIR USE AS HERBICIDES BASF SE (DE) 2024-05-30 US disclosed
CN-117806124-A Positive photosensitive polyimide resin composition 万华化学集团股份有限公司 2024-04-02 CN disclosed
EP-4305020-A1 MALONAMIDES AND THEIR USE AS HERBICIDES BASF SE (DE) 2024-01-17 EP disclosed
CN-115873069-A Peptide amide compound, pharmaceutically acceptable salt and stereoisomer thereof, and application thereof 天地恒一制药股份有限公司 2023-03-31 CN disclosed
US-20230069174-A1 NITROGEN-CONTAINING HETEROCYCLIC AUTOTAXIN INHIBITOR, AND COMPOSITION CONTAINING SAME AND USE THEREOF SICHUAN HAISCO PHARMACEUTICAL CO., LTD. (CN) 2023-03-02 US disclosed
US-20230069174-A1 NITROGEN-CONTAINING HETEROCYCLIC AUTOTAXIN INHIBITOR, AND COMPOSITION CONTAINING SAME AND USE THEREOF SICHUAN HAISCO PHARMACEUTICAL CO., LTD. (CN) 2023-03-02 US disclosed
CN-115707711-A Peptide amide compound, pharmaceutically acceptable salt, stereoisomer and application thereof 天地恒一制药股份有限公司 2023-02-21 CN disclosed
EP-4074711-A1 NITROGEN-CONTAINING HETEROCYCLIC AUTOTAXIN INHIBITOR, AND COMPOSITION CONTAINING SAME AND USE THEREOF Sichuan Haisco Pharmaceutical Co., Ltd. (CN) 2022-10-19 EP disclosed
US-20130251761-A1 ORGANIC COMPOUNDS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-09-26 US disclosed
WO-2013109632-A2 ORGANIC COMPOUNDS THE ROCKEFELLER UNIVERSITY (US) 2013-07-25 WO disclosed
US-7179906-B2 Asymmetric benzoxanthene dyes APPLERA CORPORATION (US) 2007-02-20 US disclosed
CN-1045431-C 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics FOURNIER IND & SANTE (FR) 1999-10-06 CN disclosed
US-5637613-A ANTITUMOR AGENT; IMMUNOSUPPRESSANTS FOURNIER INDUSTRIE ET SANTE (FR) 1997-06-10 US disclosed
CN-1095709-A 15-deoxyspergualin analogue, its preparation method and therepic use thereof FOURNIER IND & SANTE (FR) 1994-11-30 CN disclosed
EP-0334966-B1 PROCESS FOR SYNTHESIZING OPTICALLY ACTIVE COMPOUNDS NGK INSULATORS LTD (JP) 1994-08-24 EP disclosed
EP-0334966-A1 PROCESS FOR SYNTHESIZING OPTICALLY ACTIVE COMPOUNDS NGK INSULATORS, LTD. (JP) 1989-10-04 EP disclosed
EP-0167179-A1 Alpha-substituted-alpha-fluoro-alpha-cyanoacetic acids and their derivatives Daikin Kogyo Co., Ltd. (JP) 1986-01-08 EP disclosed
EP-0102086-A2 Alpha-substituted-alpha-fluoro-alpha-cyanoacetic acid or its derivatives Daikin Kogyo Co., Ltd. (JP) 1984-03-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230069174-A1 NITROGEN-CONTAINING HETEROCYCLIC AUTOTAXIN INHIBITOR, AND COMPOSITION CONTAINING SAME AND USE THEREOF ENPP2, NMT2, NMT1 ALDH1A1 4631/4885LMNA 1774/4885HSD17B10 1917/4885
US-20240174599-A1 MALONAMIDES AND THEIR USE AS HERBICIDES DDT, ME1, CBR3 ALDH1A1 538/4885LMNA 3999/4885HSD17B10 907/4885
US-20130251761-A1 ORGANIC COMPOUNDS PLAT, ICAM1, VCAM1 ALDH1A1 452/4885LMNA 3156/4885HSD17B10 1526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.